Stocksigma LogoStocksigma Logo

Nath Bio-Genes to Consider Q2 and H1 FY27 Financial Results on 14th Nov'26

Nath Bio-Genes (India) Ltd has scheduled a Board of Directors meeting on 14th Nov'26 to consider, approve, and take on record the standalone and

Nath Bio-Genes to Consider Q2 and H1 FY27 Financial Results on 14th Nov'26

Nath Bio-Genes (India) Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Nath Bio-Genes to Consider Q2 and H1 FY27 Financial Results on 14th Nov'26 Nath Bio-Genes (India) Ltd has scheduled a Board of Directors meeting on 14th Nov'26 to consider, approve, and take on record the standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. In accordance with insider trading regulations, the company's trading window closed on 30th Sep'26 and will reopen on 17th Nov'26.

Original exchange filing (PDF)

More announcements from Nath Bio-Genes (India) Ltd

All Nath Bio-Genes (India) Ltd announcements